Phibro Animal Health (NASDAQ:PAHC) Shares Gap Down – Here’s What Happened

by · The Markets Daily

Phibro Animal Health Corporation (NASDAQ:PAHC – Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $40.41, but opened at $39.01. Phibro Animal Health shares last traded at $38.1850, with a volume of 68,261 shares traded.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on PAHC. Bank of America lifted their target price on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research report on Friday, August 29th. JPMorgan Chase & Co. lifted their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Monday. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 9th. Finally, Morgan Stanley set a $34.00 target price on shares of Phibro Animal Health in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $31.40.

Check Out Our Latest Report on Phibro Animal Health

Phibro Animal Health Trading Down 6.9%

The company has a debt-to-equity ratio of 2.32, a current ratio of 3.09 and a quick ratio of 1.35. The firm has a fifty day simple moving average of $41.48 and a two-hundred day simple moving average of $34.96. The firm has a market capitalization of $1.52 billion, a P/E ratio of 22.69, a price-to-earnings-growth ratio of 1.15 and a beta of 0.77.

Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.The company had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, equities research analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th were given a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, November 26th. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. Phibro Animal Health’s payout ratio is 28.92%.

Insider Buying and Selling

In related news, CEO Jack Bendheim sold 38,303 shares of Phibro Animal Health stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $45.29, for a total value of $1,734,742.87. Following the completion of the transaction, the chief executive officer directly owned 20,577 shares in the company, valued at approximately $931,932.33. The trade was a 65.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders have sold 146,554 shares of company stock valued at $6,338,444. 50.13% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Phibro Animal Health

A number of institutional investors have recently made changes to their positions in PAHC. Tudor Investment Corp ET AL lifted its stake in shares of Phibro Animal Health by 3.4% in the 3rd quarter. Tudor Investment Corp ET AL now owns 10,184 shares of the company’s stock valued at $412,000 after acquiring an additional 338 shares during the last quarter. Danske Bank A S purchased a new position in shares of Phibro Animal Health in the third quarter worth $955,000. Advisory Services Network LLC bought a new stake in Phibro Animal Health during the 3rd quarter valued at $96,000. Dark Forest Capital Management LP purchased a new stake in Phibro Animal Health during the 3rd quarter valued at $2,751,000. Finally, Virtus Advisers LLC boosted its position in Phibro Animal Health by 922.9% during the 3rd quarter. Virtus Advisers LLC now owns 48,576 shares of the company’s stock valued at $1,965,000 after buying an additional 43,827 shares during the period. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.

See Also